title: Spontaneous superficial venous thrombophlebitis: does it increase risk for thromboembolism? A historic follow-up study in primary care.
abstract: OBJECTIVE
  To determine the risk of arterial and venous complications after a spontaneous superficial venous thrombophlebitis (SVTP) in the leg in a general practice population.
  
  
  METHODS
  Retrospective cohort study (LOE: 2b [CEBM]). Exposure consisted of the diagnosis of SVTP of the lower limbs on an index date. The exposed cohort was compared with an (unexposed) cohort of practice-, age-, and sex-matched controls without SVTP.
  
  
  METHODS
  Patients with spontaneous SVTP in the leg were identified through diagnostic coding in the medical registers of 40,013 patients, enlisted with 5 health centers in Amsterdam, The Netherlands.
  
  
  RESULTS
  Primary outcomes were deep venous thrombosis (DVT), pulmonary embolism (PE), acute coronary events, or ischemic stroke over a 6-month follow-up period. Odds ratios (OR) were used to quantify the associations between SVTP and outcome events.
  
  
  RESULTS
  No statistically significant odds ratios were found for PE, coronary events or stroke. DVT was the only primary outcome to show a significant relationship. DVT occurred in 2.7% of all SVTP patients as compared with 0.2% in the controls (OR=10.2; 95% confidence interval [CI], 2.0-51.6). When controlling for prior history of DVT, the OR decreased to 7.1 and the confidence interval crossed 1.0 (95% CI, 0.9-65.6).
  
  
  CONCLUSIONS
  Spontaneous SVTP in the leg is a risk factor for DVT, but is less predictive in patients with prior DVT. Although effective treatments for the prevention of DVT are available, the absolute risk is too low to advocate prophylaxis in a general practice population. More research on prophylaxis is needed to stratify these patients at risk.
authors.affiliation: Department of General Practice, Academic Medical Centre/University of Amsterdam, The Netherlands. h.c.vanweert@amc.uva.nl
authors.forename: H
authors.initials: H
authors.lastname: van Weert
authors.forename: G
authors.initials: G
authors.lastname: Dolan
authors.forename: I
authors.initials: I
authors.lastname: Wichers
authors.forename: C
authors.initials: C
authors.lastname: de Vries
authors.forename: G
authors.initials: G
authors.lastname: ter Riet
authors.forename: H
authors.initials: H
authors.lastname: Buller
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001458:Bandages; D005194:Family Practice; D005260:Female; D006801:Humans; D008297:Male; D011320:Primary Health Care; D011655:Pulmonary Embolism / Q000209:etiology*; D012189:Retrospective Studies; D013923:Thromboembolism / Q000209:etiology*; D013924:Thrombophlebitis / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D020246:Venous Thrombosis / Q000209:etiology*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal